Free tool
FAERS Monitor: Lopressor
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 218698 or its brand name (Lopressor, Metoprolol Tartrate). Reports on generic versions are filed under their own applications.
Reports
86,471
Serious
59,888
69% of reports
Hospitalization
34,683
Death reported
9,924
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- fatigue5,878
- nausea5,108
- dyspnoea5,035
- diarrhoea5,014
- dizziness3,953
- death3,874
- drug ineffective3,796
- pain3,713
- asthenia3,684
- headache3,255
- fall3,119
- myocardial infarction3,041
- off label use2,867
- pneumonia2,842
- hypotension2,688
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 1,399 |
| 2005 | 1,811 |
| 2006 | 2,035 |
| 2007 | 1,422 |
| 2008 | 3,265 |
| 2009 | 2,706 |
| 2010 | 3,627 |
| 2011 | 5,835 |
| 2012 | 5,503 |
| 2013 | 2,009 |
| 2014 | 3,994 |
| 2015 | 4,233 |
| 2016 | 5,398 |
| 2017 | 5,594 |
| 2018 | 5,556 |
| 2019 | 5,428 |
| 2020 | 4,735 |
| 2021 | 3,713 |
| 2022 | 3,691 |
| 2023 | 3,488 |
| 2024 | 3,430 |
| 2025 | 4,141 |
| 2026 | 3,456 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,967,688 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| myocardial infarctionSignal | 3,041 | 4.3 | 4.1 | 7,619 |
| hypotensionSignal | 2,688 | 3.3 | 3.2 | 4,266 |
| astheniaSignal | 3,684 | 2.4 | 2.3 | 3,022 |
| fallSignal | 3,119 | 2.3 | 2.2 | 2,284 |
| dyspnoeaSignal | 5,035 | 2.2 | 2.1 | 3,249 |
| pneumoniaSignal | 2,842 | 2.1 | 2.1 | 1,748 |
| dizziness | 3,953 | 1.9 | 1.9 | 1,814 |
| diarrhoea | 5,014 | 1.9 | 1.8 | 2,174 |
| fatigue | 5,878 | 1.8 | 1.8 | 2,334 |
| nausea | 5,108 | 1.6 | 1.5 | 1,102 |
| pain | 3,713 | 1.5 | 1.4 | 577 |
| headache | 3,255 | 1.3 | 1.2 | 184 |
| death | 3,874 | 1.1 | 1.1 | 33 |
| off label use | 2,867 | 0.8 | 0.8 | 156 |
| drug ineffective | 3,796 | 0.7 | 0.7 | 520 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.